The January edition of Journal Club, hosted by Dr. Oliver Medvedik, took a look at the results of a recent human trial in which the drug rapamycin was used to treat skin aging with some promising results.
We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.
All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.
CHOOSE AN AMOUNT TO
GIVE PER MONTH
Partial Reprogramming Extends Lifespan in Old Mice
Rapamycin extends life span & health span in mice & Daphnia
Short-Term Rapamycin Treatment Extends Lifespan in Flies
Old Plasma Dilution Reduces Human Biological Age
Tags: Journal Club, Oliver Medvedik, Rapalogs, Rapamycin, Skin
Write a comment: